Search Within

Jedd D Wolchok

Formats
  1. Journal Article (450)
  2. Meeting Abstract (414)
  3. Book Section (19)
  4. Editorial (9)
  5. Review (5)
  6. Correspondence (3)
  7. Research Letter (3)
  8. Book Whole (1)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (905)
  2. GSK Faculty (905)
  3. Melanoma and Immunotherapeutics Service (905)
  4. Solid Tumor Oncology Division (905)
  5. Melanoma Disease Management Team (222)
  6. Sloan Kettering Institute Postdocs (195)

More Groups

People
  1. Taha Merghoub (230)
  2. Michael Postow (158)
  3. Alan Houghton (118)
  4. Margaret Callahan (113)
  5. Paul Chapman (107)
  6. Katherine Panageas (92)

More People

Years
  1. 2024 (2)
  2. 2023 (15)
  3. 2022 (46)
  4. 2021 (42)
  5. 2020 (46)
  6. 2019 (47)

More Years

Publications
  1. Journal of Clinical Oncology (171)
  2. Journal for ImmunoTherapy of Cancer (81)
  3. Cancer Research (59)
  4. Clinical Cancer Research (35)
  5. Annals of Oncology (34)
  6. European Journal of Cancer (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (171)
  2. American Association for Cancer Research (130)
  3. Biomed Central Ltd (83)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (52)
  6. Oxford University Press (44)

More Publishers

Results (905)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of the safety, tolerability, pharmacokinetics, and immunoregulatory activity of urelumab (BMS-663513) in subjects with advanced and/or metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL)
    Meeting Abstract

    Melero, I.; Gangadhar, T. C.; Kohrt, H. E.; Segal, N. H.; Logan, T.; Urba, W. J.; Hodi, F. S.; Ott, P. A.; Perez-Gracia, J. L.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials
    Meeting Abstract

    Lebbé, C.; Weber, J. S.; Maio, M.; Neyns, B.; Harmankaya, K.; Hamid, O.; O'Day, S.; Chin, K. M.; McDowell, D. O.; Cykowski, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study of preoperative, single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Sung, J. S.; Blum, B.; Neville, D. A.; Kotin, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma
    Journal Article

    Barker, C. A.; Postow, M. A.; Khan, S. A.; Beal, K.; Parhar, P. K.; Yamada, Y.; Lee, N. Y.; Wolchok, J. D.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1-innate lymphoid cells
    Meeting Abstract

    Moskalenko, M.; Pan, M.; Hashimoto, D.; Mortha, A.; Bernardo, S. G.; Leboeuf, M.; Houghton, A.; Wolchok, J.; Burakoff, S.; Merad, M.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A pilot study of pre-operative (Pre-op), single-dose ipilimumab (Ipi) andlor cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J.; Blum, B.; Yuan, J.; Patil, S.; Neville, D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Immune co-signaling to treat cancer
    Book Section

    Callahan, M. K.; Wolchok, J. D.; Allison, J. P.; Sharma, P.
    In Curiel, T. J. (Eds.) Cancer Immunotherapy: Paradigms, Practice and Promise (2013)

    Fulltext@MSK | Save